GD-SIROLIMUS
GD-SIROLIMUS
Approved
DIN Number
02373394
Drug Class
Human
Market Date
N/A
Company
HC
genmed a division of pfizer canada ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02373394
AIG Number0142721001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AH01 SIROLIMUS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification90:28.24.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
SIROLIMUSActive
Strength: 1 MG
Monograph: SIROLIMUS